Inventor · disambiguated record
Alejandro A. Aruffo
Also filed as: ARUFFO ALEJANDRO · ARUFFO ALEJANDRO A
30 granted patents·3 pending applications·2,060 citations·filing 1991–2008
98Inventor score
Top patents by PatentIndex Score
33 records- 0197US5916560AMethods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewithBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Jun 29, 1999·175 cites·24 claims
- 0296US6051228AAntibodies against human CD40BRISTOL MYERS SQUIBB CO·Filed 1998·Granted Apr 18, 2000·202 cites·17 claims
- 0395US5747037AAnti-GP39 antibodiesBRISTOL MYERS SQUIBB CO·Filed 1995·Granted May 5, 1998·97 cites·8 claims
- 0495US5709859AMixed specificity fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 1991·Granted Jan 20, 1998·143 cites·22 claims
- 0594US6210669B1Methods and compositions for immunomodulationBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Apr 3, 2001·194 cites·9 claims
- 0694US5876718AMethods of inducing T cell non-responsiveness to transplanted tissues and of treating graft-versus-host-disease with anti-gp39 antibodiesDARTMOUTH COLLEGE·Filed 1998·Granted Mar 2, 1999·86 cites·8 claims
- 0793US5849898ACD40 coding sequencesGEN HOSPITAL CORP·Filed 1995·Granted Dec 15, 1998·133 cites·2 claims
- 0893US5506126ARapid immunoselection cloning methodGEN HOSPITAL CORP·Filed 1993·Granted Apr 9, 1996·171 cites·16 claims
- 0992US5540926ASoluble and its use in B cell stimulationBRISTOL MYERS SQUIBB CO·Filed 1992·Granted Jul 30, 1996·96 cites·18 claims
- 1091US5876950AMonoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapyBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Mar 2, 1999·115 cites·50 claims
- 1190US6312693B1Antibodies against human CD40Filed 1999·Granted Nov 6, 2001·68 cites·26 claims
- 1289US7119183B2Rapid immunoselection cloning methodGEN HOSPITAL CORP·Filed 2001·Granted Oct 10, 2006·20 cites·1 claims
- 1387US5993800AMethods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligandBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Nov 30, 1999·93 cites·10 claims
- 1486US6376459B1Inhibiting B cell activation with soluble CD40 or fusion proteins thereofBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Apr 23, 2002·58 cites·12 claims
- 1585US6312692B1Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cellsDARTMOUTH COLLEGE·Filed 1998·Granted Nov 6, 2001·46 cites·12 claims
- 1685US5663151ASulfated α-glycolipid derivatives as cell adhesion inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Sep 2, 1997·68 cites·42 claims
- 1784US5830731ACloning vector, polylinker and methodsGEN HOSPITAL CORP·Filed 1997·Granted Nov 3, 1998·43 cites·13 claims
- 1879US6413514B1Methods of using antibodies against human CD40BRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jul 2, 2002·35 cites·10 claims
- 1978US5945513AFusion proteins comprising gp39 and CD8BRISTOL MYERS SQUIBB CO·Filed 1996·Granted Aug 31, 1999·25 cites·2 claims
- 2076US6372215B1Monoclonal antibodies to human CD6BRISTOL MYERS SQUIBB CO·Filed 1998·Granted Apr 16, 2002·55 cites·16 claims
- 2176US5597707ATumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their useBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Jan 28, 1997·41 cites·13 claims
- 2274US6472510B1CD40 receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Oct 29, 2002·35 cites·8 claims
- 2367US2009186037A1Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewithBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 2461US5998172AAnti-CD6 ligand antibodiesUNIV DUKE·Filed 1996·Granted Dec 7, 1999·16 cites·3 claims
- 2557US2002031510A1Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewithBRISTOL MYERS SQUIBB CO·Filed 2001·Application pending·0 cites
- 2656US6218525B1Nucleic acid encoding CD28GEN HOSPITAL CORP·Filed 1992·Granted Apr 17, 2001·12 cites·16 claims
- 2756US2005202011A1Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewithFiled 2005·Application pending·0 cites
- 2852US5861151ASoluble fusion molecules with binding specificity for cell adhesion moleculesBRISTOL MYERS SQUIBB CO·Filed 1991·Granted Jan 19, 1999·10 cites·17 claims
- 2947US6046314ASpα: a novel scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies theretoBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Apr 4, 2000·7 cites·5 claims
- 3046US5968768ACD6 ligand encoding sequenceUNIV DUKE·Filed 1995·Granted Oct 19, 1999·4 cites·9 claims
- 3144US5565433ASulfated β-glycolipid derivatives as cell adhesion inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Oct 15, 1996·5 cites·38 claims
- 3233US5723437ACD6 ligandUNIV DUKE·Filed 1994·Granted Mar 3, 1998·2 cites·6 claims
- 3331US6559287B1Artificial proteoglycansBRISTOL MYERS SQUIBB CO·Filed 1999·Granted May 6, 2003·5 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →